Cellular Matrix A-CP-HA

Synergistically combines the complementary clinical effects of PRP and HA to provide added benefit for OA patients.

A-PRP: The patient’s platelet concentrate prepared with Cellular Matrix, provides an autologous reservoir of growth factors.

CellularMatrix A-CP-HA – Medical Device Class III – CE2797. Fully license to used as combination therapeutic, Cellular Matrix is a cell-friendly network that contains 2ml of HA at a concentration of 20mg/ml (40mg total), in addition to the thixotropic cell-separation gel and the sodium citrate anticoagulant solution.

CONTACT US FOR INFORMATION
SKUs

A-CP-HA-3
Cellular Matrix PRP + HA x3, Ex. Accessory Kit (6ml Blood Draw)
Clinical Studies

Author

Title

Ciapini, G. et al. (2023)

“Is the Combination of Platelet-Rich Plasma and Hyaluronic Acid the Best Injective Treatment for Grade II-III Knee Osteoarthritis? A Prospective Study,” Advances in Orthopedics, 2023, pp. 1–6.

For any product information or to order, please get in touch

Get In Touch